The Discounted Cash Flow (DCF) valuation of Translate Bio Inc (TBIO) is (131.71) USD. With the latest stock price at 3.23 USD, the upside of Translate Bio Inc based on DCF is -4177.8%.
Based on the latest price of 3.23 USD and our DCF valuation, Translate Bio Inc (TBIO) is a sell. selling TBIO stocks now will result in a potential gain of 4177.8%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 7.3% - 11.4% | 9.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (292.89) - (87.01) | (131.71) |
| Upside | -9167.9% - -2793.9% | -4177.8% |